Current perspectives in Leber congenital amaurosis type 8 mouse modeling

Area of Science:

• Ophthalmology
• Genetics
• Developmental Biology

Background:

• Mutations in CRB1 cause rare retinal dystrophies, including retinitis pigmentosa type 12 (RP12) and Leber congenital amaurosis type 8 (LCA8).
• LCA8 is characterized by severe visual impairment at birth, unlike RP12's progressive peripheral vision loss.
• Existing mouse models often fail to fully recapitulate LCA8's complex retinal pathologies.

Purpose of the Study:

• To identify and characterize the most accurate mouse model for Leber congenital amaurosis type 8 (LCA8).
• To understand the developmental basis of LCA8, which differs from other LCA subtypes and RP12.

Main Methods:

• Utilized the Cre-loxP system to ablate CRB1 and CRB2 genes in specific retinal cell types and developmental stages.
• Focused on models targeting both CRB1 and CRB2 from early eye development (optic vesicle or earlier).
• Evaluated models based on replicating LCA8-specific pathologies: disorganized retinal layering, thickening, pigmentary defects, and electroretinogram responses.

Main Results:

• The mRx-Cre mediated ablation of Crb1 and Crb2 from early development yielded the most comprehensive LCA8-like phenotype.
• This model exhibited blindness at eye-opening, retinal pigment epithelium (RPE) pigmentary defects, ganglion cell layer heterotopia, disrupted retinal lamination, and acellular patches.
• LCA8's pathology stems from dysfunctional retinal progenitor cells during development, distinct from photoreceptor defects in other LCA types and RP12.

Conclusions:

• Targeting both CRB1 and CRB2 alleles in the optic vesicle or earlier is essential for an accurate LCA8 mouse model.
• This developmental targeting approach successfully replicates key features of human LCA8, aiding further research.
• The identified model provides a valuable tool for investigating LCA8 pathogenesis and potential therapeutic strategies.